Vertex Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $940.0M | $714.8M |
| FY2016 | — | $1.16B | $1.18B |
| FY2017 | — | $2.03B | $1.67B |
| FY2018 | — | $4.44B | $2.65B |
| FY2019 | — | $6.09B | $3.11B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $940.0M | $714.8M |
| FY2016 | — | $1.16B | $1.18B |
| FY2017 | — | $2.03B | $1.67B |
| FY2018 | — | $4.44B | $2.65B |
| FY2019 | — | $6.09B | $3.11B |